B

BranchLab

AI-driven healthcare ad targeting with privacy

Healthcare Audience Strategist

Full-Time
No salary listed
Mid
Boulder, CO, USA
In Person
Data & AnalyticsData Analysis
No H1B Sponsorship

About the job

Requirements
  • Significant experience working with medical and pharmacy claims data.
  • Experience defining patient cohorts, phenotypes, treatment journeys, or healthcare audiences.
  • Strong familiarity with healthcare coding systems such as ICD-10-CM, CPT, HCPCS, and NDC.
  • Understanding of the strengths and limitations of claims data when identifying patient populations.
  • Ability to translate clinical and analytical concepts into clear recommendations for non-technical stakeholders.
  • Experience working directly with pharmaceutical, agency, or healthcare customers.
  • Strong judgment and comfort operating in situations where there is not a single objectively correct audience definition.
  • Experience partnering with data scientists, analysts, and technical teams.
Responsibilities
  • Review healthcare audience definitions and identify opportunities to improve real-world outcomes and ROI.
  • Evaluate diagnosis, procedure, treatment, pharmacy, and other healthcare signals used to identify audience populations.
  • Understand the clinical and treatment journey behind an audience rather than evaluating individual codes in isolation.
  • Identify overly restrictive, duplicative, or potentially irrelevant criteria within customer-provided audience definitions.
  • Recommend alternative audience strategies when a traditional claims-based definition may not be sufficient.
  • Partner with Data Science and AI Engineering to develop more sophisticated approaches using additional data sources or predictive methodologies.
  • Help customers understand the tradeoffs between measurement-aligned definitions, clinically expanded definitions, and more predictive audience strategies.
  • Create clear, evidence-based recommendations that Customer Success teams can confidently communicate to customers.
  • Develop reusable audience-design frameworks, playbooks, and best practices for common therapeutic areas and audience types.
  • Train Platform Operations and Customer Success teams on healthcare data, patient journeys, and audience-design principles.
  • Help establish a consistent methodology for evaluating and documenting audience quality.
Desired Qualifications
  • Experience with pharmaceutical marketing, healthcare advertising, audience activation, or healthcare measurement platforms is a strong plus.

About the company

BranchLab is a data science firm focused on healthcare advertising. It uses artificial intelligence and machine learning to build custom audience models that align with each client’s goals, enabling more precise targeting and better insights for campaigns. The core service helps healthcare brands, their agencies, and TV partners improve return on ad spend while staying compliant with privacy requirements. An ID-less approach keeps consumer health records unlinked from any user ID, prioritizing privacy. BranchLab’s offerings are tailored data solutions that enhance advertising effectiveness and protect personal information, with revenue coming from partnerships with healthcare brands and advertising agencies.

Company Size

51-200

Company Stage

Series A

Total Funding

$26M

Headquarters

New York City, New York

Founded

2024

Get referred to BranchLab

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BranchLab closed a $26 million Series A on May 13, 2026.
  • Dentsu integrated Pathwai on February 11, 2026, expanding distribution across healthcare media.
  • Privacy Updates launched August 19, 2026, covering eight states and weekly expansion.

What critics are saying

  • State privacy rules and HIPAA enforcement threaten Pathwai if de-identified data becomes re-identifiable.
  • BranchLab depends on dentsu and McKesson relationships for revenue momentum.
  • If regulators reject BranchLab's de-identification claims, Pathwai's core model collapses.

What makes BranchLab unique

  • Pathwai turns de-identified health outcomes into demographic audience segments, not raw patient IDs.
  • BranchLab pairs healthcare privacy expertise with AI commercialization tooling and state-law intelligence.
  • McKesson Ventures, Sanofi Ventures, and dentsu validate BranchLab’s platform in 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Company Equity
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

31%

1 year growth

31%

2 year growth

31%
PR Newswire
Aug 19th, 2026
BranchLab launches privacy tracker to help healthcare marketers navigate US state-by-state regulations

BranchLab has launched Privacy Updates for Marketing Activation, a resource providing state-by-state legal intelligence on how privacy developments affect healthcare advertising and commercialisation. The service initially covers eight US states — California, Connecticut, Illinois, Maryland, New Jersey, New York, Texas, and Washington — selected for their significance to healthcare privacy. Coverage will expand to all 50 states. The resource connects legislation, regulation, enforcement, and case law to healthcare marketing decisions. It builds on BranchLab's Semantic Activation Platform for healthcare commercialisation, where privacy and responsible data use are central features. "Privacy has become one of the defining considerations affecting healthcare commercialisation," said Josh Walsh, chief executive officer of BranchLab. The service is available at the company's website and is provided for informational purposes only.

PR Newswire
May 13th, 2026
BranchLab raises $26M led by McKesson Ventures for AI pharma platform that boosts marketing efficacy 70%

BranchLab, an AI platform for pharmaceutical commercialisation, has raised $26 million in Series A funding led by McKesson Ventures, bringing total funding to $35 million. FCA Venture Partners, Sanofi Ventures and AIX Ventures participated in the round. The Boulder-based company replaces fragmented pharma commercialisation workflows with a unified AI platform that enables real-time patient and healthcare professional audience identification and activation. BranchLab reports its platform has delivered a nearly 70% increase in marketing efficacy across therapeutic areas for pharmaceutical clients. The platform uses a transformer-based architecture that trains models on health data within customer-controlled environments whilst deploying only non-sensitive demographic signals. BranchLab will use the funding to expand enterprise deployments and deepen healthcare ecosystem integrations.

PR Newswire
Feb 11th, 2026
Dentsu partners with BranchLab to use AI for privacy-conscious healthcare audience targeting

Dentsu, a global media and marketing leader, has partnered with BranchLab to integrate the AI company's Pathwai™ platform for healthcare audience targeting. The collaboration transforms dentsu's proprietary data into healthcare-relevant segments anticipated to match or exceed traditional medical claims-based targeting methods. Pathwai™ uses neural networks trained on anonymised health outcomes to create privacy-conscious audience segments for healthcare marketing. The platform enables dentsu to design and activate audiences based on diagnoses, prescriptions and procedures across streaming, programmatic and social media channels. The partnership unlocks new value from dentsu's consumer dataset whilst maintaining HIPAA compliance and state privacy regulations. BranchLab's deep learning architecture translates anonymous patient journeys into targetable segments, with supervised AI learning continuously refining models based on real-world health outcomes.

PR Newswire
Sep 8th, 2025
Next Ventures Invests in BranchLab AI

Next Ventures has announced a strategic investment in BranchLab, an AI-native technology company specializing in privacy-first, outcome-based advertising for healthcare. This investment aims to accelerate AI innovation in precision healthcare by leveraging non-health data to optimize real-world health outcomes. BranchLab's platform, Pathwai™, enables brands to design and measure audiences for healthcare marketing. The partnership aligns with Next Ventures' mission to promote proactive healthcare engagement.

Business Wire
Jun 7th, 2024
BranchLab Launches Privacy-Safe Healthcare Advertising Solution with Seed Funding Round

BranchLab, a data science company developing advanced AI software that enables healthcare brands to reach the right consumers, today announced the clo